0000899243-22-017084.txt : 20220506 0000899243-22-017084.hdr.sgml : 20220506 20220506160542 ACCESSION NUMBER: 0000899243-22-017084 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220505 FILED AS OF DATE: 20220506 DATE AS OF CHANGE: 20220506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Klee Justin B. CENTRAL INDEX KEY: 0001898314 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41199 FILM NUMBER: 22901021 MAIL ADDRESS: STREET 1: C/O AMYLYX PHARMACEUTICALS, INC. STREET 2: 43 THORNDIKE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amylyx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001658551 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464600503 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 43 THORNDIKE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-683-0917 MAIL ADDRESS: STREET 1: 43 THORNDIKE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-05 0 0001658551 Amylyx Pharmaceuticals, Inc. AMLX 0001898314 Klee Justin B. C/O AMYLYX PHARMACEUTICALS, INC. 43 THORNDIKE STREET CAMBRIDGE MA 02141 1 1 0 0 Co-Chief Executive Officer Common Stock 2022-05-05 4 M 0 334520 0.37 A 2898585 D Stock Option (right to buy) 0.37 2022-05-05 4 M 0 334520 0.00 D 2023-02-16 Common Stock 334520 0 D This option is fully vested and exercisable. /s/ Justin B. Klee 2022-05-06